A

Atea Pharmaceuticals
D

AVIR

3.36000
USD
0.11
(3.38%)
مغلق
حجم التداول
7,757
الربح لكل سهم
0
العائد الربحي
-
P/E
-2
حجم السوق
283,795,878
نظرة عامةالتوصياتالأفكار والتحليلاتالأخبار
أصول ذات صلة
    A
    ABUS
    0.01000
    (0.28%)
    3.64000 USD
    A
    ADAP
    -0.00320
    (-0.54%)
    0.58680 USD
    A
    ASND
    2.160
    (1.74%)
    126.510 USD
    C
    CRNC
    -0.09500
    (-3.02%)
    3.05000 USD
    G
    GERN
    -0.04000
    (-1.08%)
    3.66500 USD
    I
    ICHR
    -1.550
    (-4.87%)
    30.250 USD
    N
    NVAX
    0.12000
    (1.67%)
    7.32500 USD
    X
    XENE
    -1.920
    (-4.60%)
    39.850 USD
    المزيد
الأخبار

العنوان: Atea Pharmaceuticals

القطاع: Healthcare
الصناعة: Biotechnology
Atea Pharmaceuticals Inc is a clinical-stage biopharmaceutical company focused on discovering, developing, and commercializing antiviral therapeutics to improve the lives of patients suffering from serious viral infections. The company is developing its product candidate, bemnifosbuvir, for the treatment of COVID-19, the disease caused by infection with Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) and its variants and also developing bemnifosbuvir in combination with ruzasvir for the treatment of Hepatitis C (HCV).